RT Journal Article
SR Electronic
T1 Aggressive COVID-19 “second wave” in Italy
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.11.20229872
DO 10.1101/2020.11.11.20229872
A1 Zheng, Hua
A1 Bonasera, Aldo
YR 2020
UL http://medrxiv.org/content/early/2020/11/22/2020.11.11.20229872.abstract
AB A two-step model for the rise and decay of the COVID-19 is applied to the Fall resurgence of COVID-19 in Italy. Data starting from October 6, 2020 are compared to the same time interval in Italy starting from the complete lockdown on March 14, 2020. The model predicts more than 130,000 deceased by the end of the year 2020 if no effective measures are taken. If similar measures to the March ones are quickly adopted, the number of deceased may decrease to over 50,000. The situation is extremely serious and requires collaboration from everyone starting from wearing masks and other protections when social distancing is not feasible.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno fundings for this workAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:this research is exemptedAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesthe data is available on request